Envestnet Asset Management Inc. Has $11.01 Million Position in HealthEquity, Inc. (NASDAQ:HQY)

Envestnet Asset Management Inc. boosted its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 2.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 114,739 shares of the company's stock after purchasing an additional 3,178 shares during the period. Envestnet Asset Management Inc. owned about 0.13% of HealthEquity worth $11,009,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HQY. Resona Asset Management Co. Ltd. purchased a new stake in shares of HealthEquity in the fourth quarter valued at about $1,505,000. Wells Fargo & Company MN lifted its stake in HealthEquity by 4.7% in the 4th quarter. Wells Fargo & Company MN now owns 124,940 shares of the company's stock valued at $11,988,000 after buying an additional 5,594 shares in the last quarter. Grant Private Wealth Management Inc acquired a new stake in HealthEquity during the 4th quarter valued at $265,000. Motley Fool Asset Management LLC increased its position in HealthEquity by 9.7% during the fourth quarter. Motley Fool Asset Management LLC now owns 122,592 shares of the company's stock worth $11,763,000 after buying an additional 10,835 shares in the last quarter. Finally, Cinctive Capital Management LP acquired a new position in shares of HealthEquity in the fourth quarter worth $4,959,000. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Performance

Shares of HQY stock traded up $4.66 during trading hours on Wednesday, reaching $88.11. The stock had a trading volume of 118,060 shares, compared to its average volume of 767,063. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. The firm has a 50-day simple moving average of $93.48 and a 200-day simple moving average of $96.44. The firm has a market capitalization of $7.62 billion, a PE ratio of 80.83, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now directly owns 78,219 shares in the company, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the firm's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at $4,433,820.30. The trade was a 13.55 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 20,381 shares of company stock worth $1,781,432 over the last ninety days. 2.20% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on HQY shares. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their price target for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. KeyCorp cut their price objective on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Wells Fargo & Company boosted their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. Barrington Research reiterated an "outperform" rating and issued a $112.00 price target on shares of HealthEquity in a research note on Friday, April 11th. Finally, The Goldman Sachs Group dropped their price objective on HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a report on Thursday, March 27th. One investment analyst has rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, HealthEquity currently has a consensus rating of "Buy" and a consensus target price of $111.75.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.